- Home
- QMMM vs COCP Comparison
QMMM vs COCP Comparison
Compare QMMM & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QMMM
- COCP
- Stock Information
- Founded
- QMMM 2005
- COCP N/A
- Country
- QMMM Hong Kong
- COCP United States
- Employees
- QMMM N/A
- COCP N/A
- Industry
- QMMM
- COCP Biotechnology: Pharmaceutical Preparations
- Sector
- QMMM
- COCP Health Care
- Exchange
- QMMM NYSE
- COCP Nasdaq
- Market Cap
- QMMM 13.3M
- COCP 15.3M
- IPO Year
- QMMM 2024
- COCP N/A
- Fundamental
- Price
- QMMM $0.91
- COCP $1.36
- Analyst Decision
- QMMM
- COCP Strong Buy
- Analyst Count
- QMMM 0
- COCP 1
- Target Price
- QMMM N/A
- COCP $7.00
- AVG Volume (30 Days)
- QMMM 1.1M
- COCP 17.0K
- Earning Date
- QMMM 04-08-2025
- COCP 03-31-2025
- Dividend Yield
- QMMM N/A
- COCP N/A
- EPS Growth
- QMMM N/A
- COCP N/A
- EPS
- QMMM N/A
- COCP N/A
- Revenue
- QMMM $2,698,229.00
- COCP N/A
- Revenue This Year
- QMMM N/A
- COCP N/A
- Revenue Next Year
- QMMM N/A
- COCP N/A
- P/E Ratio
- QMMM N/A
- COCP N/A
- Revenue Growth
- QMMM N/A
- COCP N/A
- 52 Week Low
- QMMM $0.54
- COCP $1.35
- 52 Week High
- QMMM $13.00
- COCP $3.26
- Technical
- Relative Strength Index (RSI)
- QMMM N/A
- COCP 31.02
- Support Level
- QMMM N/A
- COCP $1.38
- Resistance Level
- QMMM N/A
- COCP $1.49
- Average True Range (ATR)
- QMMM 0.00
- COCP 0.09
- MACD
- QMMM 0.00
- COCP -0.01
- Stochastic Oscillator
- QMMM 0.00
- COCP 0.00
About QMMM QMMM HOLDINGS LIMITED
QMMM Holdings Ltd is a digital advertising and marketing production services company. It operates through its two wholly owned subsidiaries: ManyMany Creations and Quantum Matrix. It has used interactive design, animation, art-tech and virtual technologies in over 500 commercial campaigns. The company has worked with large domestic and international banks, real estate developers, amusement parks, top international athletic apparel and footwear brands, and luxury cosmetic products and international brands for their advertising and creation work in Hong Kong. Its clients include local and international banks, real-estate developers, luxury brands, high fashion houses, and theme parks.
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).